Skip to content
DraconiticResearch
Search Sources API
226,742 studies31 sourcesUpdated 50 min ago
Peer-reviewedCC BY 4.0International Journal of Molecular Sciences

A Computational Investigation of Curcumin Glucoside in α-Synuclein Aggregation: DFT Characterization, Molecular Docking, and Secondary Data Analysis

8 affiliations
  1. 1Department of Biotechnology, Koneru Lakshmaiah Education Foundation (Deemed to be University), Vaddeswaram 522302, India
  2. 2Department of Computer Science and Engineering, APJ Abdul Kalam Technological University, Thiruvananthapuram 695016, India
  3. 3Department of Computer Science and Engineering, Rajagiri School of Engineering & Technology (Autonomous), Kochi 682039, India
  4. 4PhD Program in Biosciences and Biotechnology, Faculty of Science and Technology, Universidad Tecnológica de Panamá, Panama City 0819-07289, Panama
  5. 5División de Salud y Enfermedades Humanas, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama
  6. 6School of Medicine, University College Dublin, D04 V1W8 Dublin, Ireland
  7. 7División de Bioprospección y Descubrimiento de Fármacos, Instituto de Investigaciones Científicas y Servicios de Alta Tecnología (INDICASAT AIP), Clayton, City of Knowledge, Panama City 0843-01103, Panama
  8. 8Sistema Nacional de Investigación (SNI), Secretaría Nacional de Ciencia, Tecnología e Innovación (SENACYT), Panama City 0816-02852, Panama

Abstract

Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the aggregation of α-synuclein into oligomers and amyloid fibrils. Curcumin glucoside has been investigated as a potential inhibitor of α-synuclein aggregation; however, understanding its electronic properties and predicted interactions with α-synuclein fibrils may provide additional insights into its potential molecular behavior. This study integrates density functional theory (DFT) calculations, molecular docking, and quantitative analysis of previously published Thioflavin-T (ThT) fluorescence data to investigate the physicochemical properties and potential anti-aggregation effects of curcumin glucoside. DFT calculations were performed on isolated curcumin and curcumin monoglucoside molecules using the B3LYP-D3(BJ)/def2-SVP level of theory with implicit aqueous solvation. The HOMO–LUMO energy gaps were 3.626 eV for curcumin and 3.372 eV for curcumin monoglucoside, while their dipole moments were 7.53 D and 11.19 D, respectively. These differences indicate changes in the electronic structure and molecular polarity associated with glucosylation. Molecular docking against selected α-synuclein fibril structures representing different disease stages showed docking scores ranging from −5.1 to −6.7 kcal/mol for curcumin and from −6.2 to −6.6 kcal/mol for curcumin glucoside. Previously published ThT fluorescence data related to curcumin glucoside were analyzed using a four-parameter logistic (4PL) model to characterize the reported aggregation-response profiles over time. The combined findings provide complementary electronic-structure, docking, and aggregation-kinetic perspectives on curcumin glucoside. Importantly, the DFT calculations were restricted to isolated molecules and did not evaluate electron redistribution, charge-transfer pathways, or reaction energetics within protein–ligand complexes. The docking scores are computational estimates from a scoring function and are not experimentally measured binding affinities. The 4PL analysis is a secondary re-examination of previously published ThT fluorescence data and does not constitute new experimental validation of aggregation inhibition. Collectively, these results supply a computational and quantitative descriptive basis that can guide further experimental and higher-level quantum-chemical investigation of curcumin glucoside as a potential modulator of α-synuclein aggregation; they do not, by themselves, establish a quantum-mechanical mechanism of action.

Related

  1. Aβ42-Driven α-synuclein Fibril Polymorphism and Distinct Intracellular Aggregation
    Purnopama Saha, Teshani Liyanaarachchige, Anika Alim +2
    bioRxivPreprintAll rights reservedFull textMolecular biology & gene regulationPMCbioRxiv
  2. Examining the Atypical Structure Adopted by the 37-51 Segment of α-synuclein in the Early Stage of Aggregation
    A. Guzzo, P. Delarue, K. Kachlishvili +3
    bioRxivPreprintAll rights reservedFull textBiophysicsbioRxiv
  3. Peptidomimetics Inspired by α-Synuclein or Its Chaperone αB-Crystallin Differentially Modulate α-Synuclein Aggregation
    Nicolo Bisi, Josine Kothuis, Julia Kaffy +14
    Journal of Medicinal ChemistryPeer-reviewedCC BY 4.0Full text1 citedBiophysicsStructural biologyHAL
  4. State-selective inhibition of alpha-synuclein aggregation by de novo oligomer-binding proteins
    Y. Zhang, H. L. Han, L. Ortigosa-Pascual +13
    bioRxivPreprintCC BY-NC-NDFull textBiophysicsbioRxiv
  5. Oxidized EGCG redirects α-synuclein aggregation through shear-selected interactions
    C. M. Yuen, R. Yamaguchi, K. Uchida +8
    bioRxivPreprintCC BYFull textGeneral biochemistrybioRxiv
BibTeX
@article{emani2026computational,
  title = {{A Computational Investigation of Curcumin Glucoside in α-Synuclein Aggregation: DFT Characterization, Molecular Docking, and Secondary Data Analysis}},
  author = {Lakshmi Sowmya Emani and Pranathi Jalapally and Gerardo Samudio-Ríos and Jayanth KS Rao and Sminu Izudheen and Johant Lakey-Beitia and K.S Jagannatha Rao},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  month = nov,
  doi = {10.3390/ijms272210158},
  url = {https://www.mdpi.com/1422-0067/27/22/10158},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - A Computational Investigation of Curcumin Glucoside in α-Synuclein Aggregation: DFT Characterization, Molecular Docking, and Secondary Data Analysis
AU  - Lakshmi Sowmya Emani
AU  - Pranathi Jalapally
AU  - Gerardo Samudio-Ríos
AU  - Jayanth KS Rao
AU  - Sminu Izudheen
AU  - Johant Lakey-Beitia
AU  - K.S Jagannatha Rao
PY  - 2026
DA  - 2026/11/12
JO  - International Journal of Molecular Sciences
DO  - 10.3390/ijms272210158
UR  - https://www.mdpi.com/1422-0067/27/22/10158
AB  - Parkinson’s disease (PD) is a progressive neurodegenerative disorder characterized by the aggregation of α-synuclein into oligomers and amyloid fibrils. Curcumin glucoside has been investigated as a potential inhibitor of α-synuclein aggregation; however, understanding its electronic properties and predicted interactions with α-synuclein fibrils may provide additional insights into its potential molecular behavior. This study integrates density functional theory (DFT) calculations, molecular docking, and quantitative analysis of previously published Thioflavin-T (ThT) fluorescence data to investigate the physicochemical properties and potential anti-aggregation effects of curcumin glucoside. DFT calculations were performed on isolated curcumin and curcumin monoglucoside molecules using the B3LYP-D3(BJ)/def2-SVP level of theory with implicit aqueous solvation. The HOMO–LUMO energy gaps were 3.626 eV for curcumin and 3.372 eV for curcumin monoglucoside, while their dipole moments were 7.53 D and 11.19 D, respectively. These differences indicate changes in the electronic structure and molecular polarity associated with glucosylation. Molecular docking against selected α-synuclein fibril structures representing different disease stages showed docking scores ranging from −5.1 to −6.7 kcal/mol for curcumin and from −6.2 to −6.6 kcal/mol for curcumin glucoside. Previously published ThT fluorescence data related to curcumin glucoside were analyzed using a four-parameter logistic (4PL) model to characterize the reported aggregation-response profiles over time. The combined findings provide complementary electronic-structure, docking, and aggregation-kinetic perspectives on curcumin glucoside. Importantly, the DFT calculations were restricted to isolated molecules and did not evaluate electron redistribution, charge-transfer pathways, or reaction energetics within protein–ligand complexes. The docking scores are computational estimates from a scoring function and are not experimentally measured binding affinities. The 4PL analysis is a secondary re-examination of previously published ThT fluorescence data and does not constitute new experimental validation of aggregation inhibition. Collectively, these results supply a computational and quantitative descriptive basis that can guide further experimental and higher-level quantum-chemical investigation of curcumin glucoside as a potential modulator of α-synuclein aggregation; they do not, by themselves, establish a quantum-mechanical mechanism of action.
SN  - 1422-0067
ER  -